ALIVUS LIFE SCIENCES
Back to All Ratios
|
ALIVUS LIFE SCIENCES Last 5 Year Cash Earnings per Share (CEPS) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 44.58 | 42.79 | 41.55 | 37.27 | 35.71 |
What is the latest Cash Earnings per Share (CEPS) ratio of ALIVUS LIFE SCIENCES ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 44.58 |
| Mar2024 | 42.79 |
| Mar2023 | 41.55 |
| Mar2022 | 37.27 |
| Mar2021 | 35.71 |
How is Cash Earnings per Share (CEPS) of ALIVUS LIFE SCIENCES Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 44.58 | 4.18 | |
| Mar2024 | 42.79 | 2.98 | |
| Mar2023 | 41.55 | 11.48 | |
| Mar2022 | 37.27 | 4.37 | |
| Mar2021 | 35.71 | - | |
Other Financial Ratios of ALIVUS LIFE SCIENCES
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹11,498.2 Cr | -0.7% | 3.8% | -20.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,991.0 Cr | 0.1% | -3.2% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,371.0 Cr | -1.5% | -7.3% | 2.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,229.0 Cr | -1.3% | -0.7% | 24.4% | Stock Analytics | |
| CIPLA | ₹108,441.0 Cr | 1.5% | -8.1% | -6.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,407.0 Cr | 3.2% | 5.6% | 3.1% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | -0.7% |
3.8% |
-20.8% |
| SENSEX | 2.9% |
-1.1% |
8.5% |
You may also like the below Video Courses